August J. Moretti
2021 - 4D Molecular Therapeutics
In 2021, August J. Moretti earned a total compensation of $2.6M as Chief Financial Officer at 4D Molecular Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $139,200 |
|---|---|
| Option Awards | $2,048,585 |
| Salary | $435,000 |
| Other | $13,000 |
| Total | $2,635,785 |
Moretti received $2M in option awards, accounting for 78% of the total pay in 2021.
Moretti also received $139.2K in non-equity incentive plan, $435K in salary and $13K in other compensation.
Rankings
In 2021, August J. Moretti's compensation ranked 4,944th out of 12,415 executives tracked by ExecPay. In other words, Moretti earned more than 60.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,944 out of 12,415 | 60th |
Division Manufacturing | 2,072 out of 5,505 | 62nd |
Major group Chemicals And Allied Products | 882 out of 2,375 | 63rd |
Industry group Drugs | 789 out of 2,096 | 62nd |
Industry Biological Products, Except Diagnostic Substances | 200 out of 449 | 56th |
Source: SEC filing on April 12, 2023.
Moretti's colleagues
We found three more compensation records of executives who worked with August J. Moretti at 4D Molecular Therapeutics in 2021.